VAXXON BI GUMBORO 2 LYOPHILISATE (LIVE INTERMEDIATED VACCINE AGAINST GUMBORO DISEASE VIRUS ≥ 103 E1D50/DOSE, IN STABILIZING SOLUTION, FREEZE DRIED VACCINE)

Dosage

Children: Refer to specific drug guidelines as paediatric dosing should be determined based on age, weight, and clinical condition.

Adults: Refer to specific drug guidelines as doses can vary significantly based on the condition being treated and the pharmacological class.

Mechanism of action

The mechanism of action for drugs that act 'against' a condition typically involves inhibition of specific pathways, receptor antagonism, or modulation of biochemical processes. For example, anti-inflammatory agents may inhibit the cyclooxygenase enzyme (COX), reducing the synthesis of pro-inflammatory mediators.

Pharmacodynamics

Pharmacodynamics of drugs that act against a condition often involves altering the body's response to stimuli. This may include reducing pain and inflammation, modulating immune responses, or blocking neurotransmitter actions. The specific effects depend on the drug class and target receptors.

Pharmacokinetics

Pharmacokinetics encompasses the absorption, distribution, metabolism, and excretion of drugs acting against specific conditions. These drugs may exhibit varied half-lives, bioavailability, and routes of elimination, which influence their dosing schedules and therapeutic effects.

Contra-indications

• Hypersensitivity to the active substance or to any of the excipients
• Severe liver dysfunction
• Pregnancy (unless benefits outweigh risks)

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Fatigue
• Rash
• Elevated liver enzymes

Interactions

• Caution with concomitant use of hepatotoxic drugs
• May interact with anticoagulants, necessitating monitoring of coagulation parameters
• Potential interaction with other drugs metabolized by the liver

Precautions

• Use with caution in patients with a history of liver disease
• Monitor liver function tests during therapy
• Avoid abrupt discontinuation of therapy
• Consider potential for drug interactions

Pregnancy

The use of this drug during pregnancy should be avoided unless the potential benefits justify the potential risks to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution should be exercised when administering this drug to a breastfeeding mother.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

• Tablets
• Oral solution
• Injectable solution

Dosage

Children: Refer to specific medications used to treat the particular disease for dosing information.

Adults: Refer to specific medications used to treat the particular disease for dosing information.

Mechanism of action

The mechanism of action varies significantly depending on the specific disease in question. For infectious diseases, pathogens may interact with host cells, leading to inflammation, immune response activation, or tissue damage. Chronic diseases often involve complex interactions between genetic factors, lifestyle choices, and environmental influences. For example, in autoimmune diseases, the immune system mistakenly targets healthy cells, leading to inflammation and tissue destruction.

Pharmacodynamics

Pharmacodynamics of disease involves understanding how the disease state affects physiological functions and the body's response to treatment. In infectious diseases, the presence of pathogens can lead to altered immune responses, while chronic diseases may involve changes in metabolic pathways, hormonal balances, or cellular functions. Medications targeting disease processes aim to restore normal function, alleviate symptoms, or eradicate pathogens.

Pharmacokinetics

Pharmacokinetics is not applicable to the term 'disease' as it refers to the movement of drugs within the body, including absorption, distribution, metabolism, and excretion of specific medications used to treat diseases. Each medication will have its own pharmacokinetic profile depending on its chemical properties and the disease being treated.

Indications

• Prevention of Infectious Bursal Disease in poultry
• Immunization of chickens to reduce mortality and morbidity associated with IBD

Dosage

Children: Refer to specific vaccination guidelines for poultry, as doses vary based on the vaccine type used.

Adults: Refer to specific vaccination guidelines for poultry, as doses vary based on the vaccine type used.

Mechanism of action

The Infectious Bursal Disease Virus (IBDV) primarily infects B lymphocytes in the bursa of Fabricius, leading to apoptosis (programmed cell death) of these immune cells. This disrupts the normal immune response in birds, resulting in immunosuppression. The virus has a biphasic replication cycle, first replicating in the cytoplasm of infected cells before assembling and releasing new virions, which can then spread to other cells.

Pharmacodynamics

The pharmacodynamics of treatments for Gumboro primarily focus on the prevention of infection through vaccination. Vaccines stimulate the immune system to produce antibodies against the IBDV, enhancing the bird's ability to fight off the infection. Immunization can reduce mortality and morbidity associated with the disease, though the efficacy may vary based on the vaccine strain and timing.

Pharmacokinetics

Vaccines for Gumboro typically involve intramuscular or subcutaneous administration, allowing the active components to be absorbed into the systemic circulation. The onset of immunity varies based on the type of vaccine used, with live attenuated vaccines often providing quicker immunity than inactivated vaccines. The duration of immunity can last several weeks to months, depending on the vaccine formulation and the age of the birds at vaccination.

Dosage

Children: Refer to specific drug information for appropriate dosing.

Adults: Refer to specific drug information for appropriate dosing.

Mechanism of action

Intermediates in drug metabolism typically serve as substrates for enzymes that convert them into active pharmacological agents or further metabolites. These processes can involve various biochemical pathways, including phase I (oxidation, reduction, hydrolysis) and phase II (conjugation) reactions, which enhance the solubility and excretion of compounds.

Pharmacodynamics

The pharmacodynamics of intermediates depends on their specific role within metabolic pathways. Generally, intermediates may not exhibit direct pharmacological effects but can influence the pharmacokinetics and pharmacodynamics of the primary drug by affecting absorption, distribution, metabolism, and excretion. Their interactions can lead to the modulation of therapeutic efficacy and toxicity.

Pharmacokinetics

Pharmacokinetics of intermediates can vary widely based on the specific compound and its transformation into active metabolites. Absorption, distribution, metabolism, and excretion (ADME) profiles are influenced by factors such as chemical structure, route of administration, and the presence of other substances. Typically, intermediates are rapidly metabolized and eliminated, contributing to the overall pharmacological action of the parent compound.

Pregnancy

Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Use with caution, as it may be excreted in breast milk.

Storage

Store in a cool, dry place away from light.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, hepatitis B, influenza, and human papillomavirus (HPV)
• Travel vaccinations for diseases endemic to certain regions
• Vaccination for at-risk populations, such as those with compromised immune systems or specific occupational exposures

Dosage

Children: Dosage varies by vaccine type and age; refer to the BNF for Children for specific dosing information.

Adults: Dosage varies by vaccine type and indication; refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by mimicking an infection. They introduce a harmless component of a pathogen (antigen) to the immune system, prompting the body to produce an immune response. This includes the generation of antibodies and memory cells that provide long-term immunity. Upon subsequent exposure to the actual pathogen, the immune system is primed to respond more rapidly and effectively.

Pharmacodynamics

The pharmacodynamics of vaccines involves the activation of both humoral and cellular immunity. Vaccines stimulate B cells to produce antibodies against the pathogen, while T cells are activated to destroy infected cells. This dual response helps to establish immunological memory, which enables a faster and more robust response upon re-exposure to the pathogen.

Pharmacokinetics

Vaccines are administered via various routes, including intramuscular, subcutaneous, and oral. After administration, the antigens are presented to antigen-presenting cells, which activate T cells and stimulate B cell proliferation and differentiation. The half-life of vaccine-induced immunity varies depending on the type of vaccine, with some providing lifelong immunity and others requiring booster doses to maintain protection.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Severe immunocompromised state for live attenuated vaccines

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Nausea

Interactions

• Immunosuppressive medications may reduce vaccine efficacy
• Concurrent administration of some vaccines may require spacing to optimize immune response

Precautions

• History of allergic reactions to vaccines or vaccine components
• Pregnancy (specific vaccines may be contraindicated)
• Moderate to severe acute illness with or without fever

Pregnancy

Consult healthcare provider. Some vaccines are contraindicated during pregnancy, while others are recommended.

Breast-feeding

Generally considered safe, but consult healthcare provider regarding specific vaccines.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Liquid suspension for injection
• Lyophilized powder for reconstitution

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.